A carregar...
Do We Need Anti-Prionic Compounds to Treat Alzheimer’s Disease?
Background: While phase III clinical trials for the treatment of Alzheimer’s disease (AD) keep failing regardless of the target, more and more data suggest that the toxic protein assemblies of amyloid-beta protein (Aβ) and tubulin binding protein (TAU) behave like prions. Irrespective of the questio...
Na minha lista:
| Publicado no: | Molecules |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6637388/ https://ncbi.nlm.nih.gov/pubmed/31208037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24122237 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|